Nuclear Imaging Devices And Equipment Global Market Report 2022

·4 min read
ReportLinker
ReportLinker

Major players in the market are Toshiba Medical Systems Corporation, Neusoft Medical Systems Co. , Ltd. , SurgicEye GmbH, Siemens Healthineers, GE Healthcare, Mediso Medical Imaging Systems Ltd. , Digirad Corporation, CMR Naviscan Corporation, DDD Diagnostics, and Philips Healthcare.

New York, May 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nuclear Imaging Devices And Equipment Global Market Report 2022" - https://www.reportlinker.com/p06277189/?utm_source=GNW


The global nuclear imaging devices and equipment market is expected to grow from $3.74 billion in 2021 to $4.02 billion in 2022 at a compound annual growth rate (CAGR) of 7.7%. The market is expected to grow to $5.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%.

The nuclear imaging devices and equipment market consist of sales of nuclear imaging devices and related services. Nuclear imaging devices and equipment are used in the diagnosis of radioactive substances in patients.

The main product types in the nuclear imaging devices and equipment are SPECT systems, PET systems, and planar scintigraphy.The SPECT scan is used to capture the images and create 3D scanning.

These are used for various applications such as oncology, cardiology, neurology, other applications (orthopedics, urology, thyroid-related disorders, and gastroenterology that are used in hospitals, imaging centers, academic & research institutes, other end users (pharmaceutical/biotechnology companies and CROs).

Western Europe was the largest region in nuclear imaging devices and equipment market in 2021.North America was the second-largest region in nuclear imaging devices and equipment market.

The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The nuclear imaging devices and equipment market is being driven by increasing incidences and prevalence of diseases such as cancer, heart disease, gastrointestinal, endocrine, and neurological disorders.Such diseases are diagnosed in relatively early stages by nuclear imaging equipment as compared to other equipment.

For instance, according to the American Cancer Society 2020, in the United States, 1.8 million new cancer cases are diagnosed and 606,520 cancer deaths in the United States, many of which have been diagnosed by nuclear imaging devices and equipment.

The nuclear imaging devices and equipment market is being restrained by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC requires nuclear imaging equipment licensees to use and store radioactive materials to protect workers and common people by removing unwanted exposure, which has resulted in a relatively less number of nuclear imaging equipment being manufactured.

Companies in the nuclear imaging devices and equipment market are using hybrid imaging technologies such as positron emission tomography/computed tomography (PET/CT), single-photon emission computed tomography/computed tomography (SPECT/CT), and positron emission tomography/magnetic resonance imaging (PET/MRI)
for nuclear medical imaging. These hybrid systems provide precise images with better resolution and both morphological and physiological information in just one instance of testing. For instance, a SPECT/CT system for skeletal evaluation offers accurate localization and improves the specificity of information provided by CT.

The Nuclear Regulatory Commission (NRC), USA regulates the manufacture and use of radioactive materials in nuclear imaging devices, as well as radiation therapy and research.It has agreements with 37 US states which allows them to regulate the use of certain radioactive materials by giving licenses to hospitals, clinics, and medical centers.

The US-based Food and Drug Administration (FDA) also regulates products and procedures that are radiation-emitting. It reviews the safety and use of radiopharmaceuticals and machines like x-rays, which produce radiation but do not make or use radioactive material.

In April 2020, TTG Imaging Solutions, LLC, a company operating in nuclear medicine equipment based in the United States acquired Nuclear Imaging Services and Molecular Imaging Specialists for an undisclosed amount.With this acquisition, The company wants to expand its portfolio in diagnostics imaging.

Nuclear Imaging Services is a company operating in nuclear imaging based in texas and Molecular Imaging Specialists, a company operating in nuclear imaging devices and equipment based in the United States.

The countries covered in the nuclear imaging devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia.
Read the full report: https://www.reportlinker.com/p06277189/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting